A study out of the Imperial College London’s Centre for Psychedelic Research found that psilocybin mushrooms were effective in helping to open up the brains of participants suffering from depression, even weeks after consumption. Almost 60 subjects joined in the trials, which yielded positive results. For the methodology, researchers assessed fMRI scans of individuals from the trials: in one study all of them were given psilocybin while for another, they used a randomized control trial for general depression that assessed the efficacy of psilocybin against escitalopram, a common SSRI medication used for treating depression.
This column originally appeared in Cultivated, a cannabis industry newsletter. Subscribe here. You know the…
The DEA has opened a new registration process for state-licensed medical cannabis manufacturers, distributors and…
This November gathering will bring psychedelic education into conversation with music, visual art, comedy, philosophy,…
Ten p.m. on a Glendale balcony, two floors above the theater that just screened the…
We analyzed seven different 2026 rankings to find the true top 10 cannabis strains in…
A land-rooted look at the growers reshaping cannabis through living soil, ecological intelligence and regenerative…